Bioinformatics: Technologies and Global Markets

Report Scope:

The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.

Report Includes:

- 31 data tables and 80 additional tables
- Comprehensive details of the global bioinformatics market and relevant technologies
- Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Assessment of the market trends and analysis regarding industry service providers and software solution developers, as well as information technology (IT) and bioinformatics service providers that support the pharma and biotech industries
- Review of challenges and opportunities underlying in the bioinformatics market following the adoption of high-throughput technologies such as next-generation sequencing (NGS), the analysis of big data, and the emergence of cloud-based solutions
- Insight into the sequencing and pharmaceutical R&D applications of bioinformatics in drug development and clinical trials, including cheminformatics, next-generation sequencing, metagenomics and data management systems
- A look at the investigational new drug applications, NDA approvals, leading EHRs providers, mobile health technologies, and recent partnerships and agreements in the pharmaceutical and bioinformatic sectors
- Profile description of key pharmaceutical and biotechnology companies, including Dassault Systemes Biovia, Genedata AG, PerkinElmer Informatics Inc., Qlucore AB and Syngene International

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Intended Audience
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Global Bioinformatics Market: Overview
Goal of Bioinformatics
Biological Data Sources
Bioinformatics in Systems Biology
Precision Medicine
Bioinformatics in Drug Development
Cheminformatics
Next-Generation Sequencing
Metagenomics
Database Management Systems
Market Trends
Precision Medicine and Biomarker Identification
Cloud-Based Solutions
Shift Toward Value-Based Care
Market Challenges
Data Integration
Data Reliability and Standardization
End-to-End Workflows
Current Market
Market by Region
Market by Category
Public Funding
Private Funding
Market by Application
Chapter 4 Bioinformatics: Data Generation and Data Management
Information Overload
Data Volume
Data Variety
Data Velocity
Data Veracity
Software Scalability and Validity
Technologies Behind Big Data Generation
Genomics
Exponential Growth in NGS Software Tools
Functional Genomics
CRISPR Cas9 System
Proteomic Advances
Qualitative Proteomics
Quantitative Proteomics
Structural Proteomics
Advances in MS-Based Proteomics Technology for Exploring Triple Negative Breast Cancer
Sample Preparation Assays
Tagging/Affinity Methods
Utility of Proteomics to Identify Biomarkers
Investments in Structural Genomics and Open Science
Interaction Proteomics
Applications in Drug Discovery
Bottom-Up vs. Top-Down Proteomics
Emergence of Glycomics
Human Proteome Organization and Human Proteome Project Initiatives
Transcriptomic Advances
RNA Sequencing
Co-Expression and Single-Cell RNA-Seq
Metabolomic Advances
Advances in Cheminformatics
Emerging Technologies
Metagenomic Advances
Epigenomic Advances
Pharmacogenomic Advances
Pharmacogenomics and Precision Medicine
Value-Based Decisions
Pharmacogenomics and R&D
International Serious Adverse Events Consortium
Pharmacogenomic Software
Toxicogenomic Advances
Customized Toxicogenomic Platforms
Database Management Services
Market Dynamics
Chapter 5 Bioinformatics: Data Analysis and Software
Introduction
Data Analysis Software
Biosimulation Models
Market Analysis
Chapter 6 Bioinformatics: Data Processing and Storage
Mind the Gap
Information Technology Infrastructure
High-Performance Computing
High-Performance Computer Clusters
Cloud Computing
Data as a Service
Infrastructure as a Service
Platform as a Service
Software as a Service
Security as a Service
Cloud Computing Challenges
Future of Cloud Computing
Market Analysis
Chapter 7 Bioinformatics: Sequencing Services and Platforms
Market Analysis
Comparative Analysis Across Market Segments, 2017 and 2023
Sequencing Services
Sequencing Platforms
Sequence Analysis Platforms
Sequence Alignment Platforms
Sequence Manipulation Platforms
Chapter 8 Bioinformatics: Sequencing Applications
Market Analysis
Agrigenomics
Clinical and Medical
Genealogy
Other Fields
Chapter 9 Bioinformatic Applications in Pharmaceutical R&D
Introduction
Drug Discovery and Development Process
Target Identification
Target Validation
Lead Identification
Lead Optimization
Clinical Research: Drug Development
Preclinical Experiments
Investigational New Drug Applications
Clinical Trials
New Drug Application
NDA Approval
Post-Launch Ongoing Studies and Phase IV Clinical Trials
Electronic Health Records
Mobile Health Technologies
Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
Conclusions
Chapter 10 Market Trends and Analysis
North America
United States
Canada
Europe
United Kingdom
Germany
Switzerland
Asia-Pacific
India
China
Conclusions
Chapter 11 Company Profiles
3RD MILLENNIUM INC.
BIOMATTERS LTD. GENEIOUS
COMPUGEN LTD.
DASSAULT SYSTEMES BIOVIA
DNASTAR, INC.
GENEDATA AG
GENEVA BIOFORMATICS (GENEBIO) SA
GENOLOGICS LIFESCIENCES SOFTWARE INC.
GENOMATIX SOFTWARE GMBH
GNS HEALTHCARE INC.
GVK BIOSCIENCES PVT. LTD.
INTE LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
ILLUMINA INC.
MACVECTOR INC.
MOLECULAR CONNECTIONS PVT. LTD.
MOLECULAR NETWORKS GMBH
NONLINEAR DYNAMICS LTD.
OCIMUM BIOSOLUTIONS LTD.
PERKINELMER INFORMATICS INC.
PERSONALIS INC.
QLUCORE AB
REAL TIME GENOMICS INC.
SMARTGENE SERVICES SARL
STRAND LIFE SCIENCES
SYNGENE INTERNATIONAL

List Of Tables


Summary Table : Overall Global Bioinformatics Market, by Region, Through 2023
Table 1 : Investments in Microbiology
Table 2 : PDB Data Distribution, by Experimental Method and Molecular Type, 2017
Table 3 : RefSeq Accession Growth, 2016 and 2018
Table 4 : Sequencing Services and Platforms as Available in EBI Database
Table 5 : Recommendations for NGS Bioinformatics Tools
Table 6 : Leading Institutional Developers of Bioinformatics Tools, 2017
Table 7 : Bioinformatics Tools Used for Metagenomics Analysis
Table 8 : DBMS Platforms in Bioinformatics
Table 9 : Growth in Selected EMBL-EBI Resources, 2015-2016
Table 10 : Number of FDA and EMA Drug Approvals, 2012-2016
Table 11 : Global Bioinformatics Market, by Region, Through 2023
Table 12 : Public Funding Programs, 2012-2018
Table 13 : Global Bioinformatics Market, by Category, Through 2023
Table 14 : Global Bioinformatics Market, by Application, Through 2023
Table 15 : Cloud-Based Bioinformatics Tools
Table 16 : Commercially Available Metabolomics Software
Table 17 : Open Access Tools for Complex Liquid Chromatography-Mass Spectrometry Data Analysis
Table 18 : Cheminformatics Software Solutions for Drug R&D
Table 19 : Bioinformatic Tools for Metagenomic Studies
Table 20 : Pharmacogenomic Biomarkers in Drug Labeling
Table 21 : Recent Research on Biomarkers
Table 22 : Bioinformatic Tools and Databases Used in Pharmacogenomics
Table 23 : Bioinformatic Tools for Pharmacogenomic Studies
Table 24 : Bioinformatic Tools for Pharmacogenomic Software
Table 25 : Toxicogenomic Studies Planned or Ongoing, 2016
Table 26 : Bioinformatics Archival Databases
Table 27 : Bioinformatics Curative Databases
Table 28 : Commercially Available Bioinformatics Databases
Table 29 : Biological Databases for Human Research
Table 30 : Software for Biological Analysis
Table 31 : Open Source Bioinformatics Software
Table 32 : NGS Platforms for Clinical Diagnostics
Table 33 : Commonly Used Tools for NGS-based DNA Analysis, by Functional Category
Table 34 : Commercially Available Integrated DNA Analysis Solutions and Relevant Functionality
Table 35 : High-Performance Computing Architectures: Advantages and Drawbacks
Table 36 : Highest Performance Supercomputers, 2018
Table 37 : SaaS Products
Table 38 : Global Bioinformatics Market, by Sequencing Services and Platforms, Through 2023
Table 39 : Sequence Analysis Software
Table 40 : Sequence Alignment Platforms
Table 41 : Global Bioinformatics Market, by Sequencing Application, Through 2023
Table 42 : Sequencing Data Analysis Bioinformatics Software and Tools
Table 43 : Bioinformatics-Based Clinical and Medical Laboratory Information Management System
Table 44 : Number of Therapeutic Drugs Developed Globally, by Disease Category, 2017
Table 45 : Bioinformatics Databases
Table 46 : Leading Drug Target Databases
Table 47 : Computer Simulation Platforms
Table 48 : Application of Cloud-Based Services in Healthcare
Table 49 : Leading LIMS Providers
Table 50 : Key Suppliers of ELNs
Table 51 : Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
Table 52 : Drug R&D Process Overview
Table 53 : Leading EHR Providers, 2018
Table 54 : Medical Applications for Healthcare Professionals
Table 55 : Pharmaceutical and Bioinformatic Partnerships and Alliances, 2015-2017
Table 56 : North American Bioinformatics Market, by Country, Through 2023
Table 57 : Leading Bioinformatics Companies in the U.S.
Table 58 : Venture Capital Companies Most Active in the Biotech Sector, 2015
Table 59 : U.S. Bioinformatics Market, by Application, Through 2023
Table 60 : U.S. Bioinformatics Market, by Category, Through 2023
Table 61 : Canadian Bioinformatics Market, by Category, Through 2023
Table 62 : Leading Canadian Bioinformatics Companies
Table 63 : Canadian Bioinformatic Market, by Application, Through 2023
Table 64 : European Bioinformatics Market, by Country, Through 2023
Table 65 : Leading European Bioinformatics Companies
Table 66 : U.K. Bioinformatics Market, by Category, Through 2023
Table 67 : U.K. Bioinformatics Market, by Application, Through 2023
Table 68 : German Bioinformatics Market, by Category, Through 2023
Table 69 : German Bioinformatics Market, by Application, Through 2023
Table 70 : Swiss Bioinformatics Market, by Category, Through 2023
Table 71 : Swiss Bioinformatics Market, by Application, Through 2023
Table 72 : Asia-Pacific Bioinformatics Market, by Country, Through 2023
Table 73 : Indian Bioinformatics Market, by Category, Through 2023
Table 74 : Leading Indian Bioinformatics Companies
Table 75 : Indian Bioinformatics Market, by Application, Through 2023
Table 76 : Chinese Bioinformatics Market, by Category, Through 2023
Table 77 : Chinese Bioinformatics Market, by Application, Through 2023
Table 78 : Biomatters Ltd.: Product Portfolio
Table 79 : Compugen Ltd.: Product Portfolio
Table 80 : Dassault Systemes Biovia: Product Portfolio
Table 81 : DNASTAR Inc.: Product Portfolio
Table 82 : DNASTAR Inc.: Recent Developments, 2016
Table 83 : Genedata AG: Product Portfolio
Table 84 : Genedata AG: Recent Developments, 2017
Table 85 : Geneva Bioformatics (GeneBio) SA: Product Portfolio
Table 86 : Genologics Lifesciences Software Inc.: Product Portfolio
Table 87 : Genomatix Software GmbH: Product Portfolio
Table 88 : GNS Healthcare Inc.: Product Portfolio
Table 89 : GNS Healthcare Inc.: Recent Developments, 2015-2017
Table 90 : GVK Biosciences Pvt. Ltd.: Product Portfolio
Table 91 : GVK Biosciences Pvt. Ltd: Recent Developments, 2017
Table 92 : Inte: Ligand Software Entwicklungs Und Consulting GmbH: Product Portfolio
Table 93 : Illumina Inc.: Product Portfolio
Table 94 : Illumina Inc.: Recent Developments, 2016-2017
Table 95 : MacVector Inc.: Product Portfolio
Table 96 : Molecular Connections Pvt. Ltd.: Product Portfolio
Table 97 : Molecular Networks GmbH: Product Portfolio
Table 98 : Nonlinear Dynamics Ltd.: Product Portfolio
Table 99 : Ocimum Biosolutions Ltd.: Product Portfolio
Table 100 : PerkinElmer Informatics Inc.: Product Portfolio
Table 101 : Qlucore AB: Product Portfolio
Table 102 : Qlucore AB: Product Portfolio
Table 103 : Qlucore AB: Recent Developments, 2018
Table 104 : Real Time Genomics Inc.: Product Portfolio
Table 105 : Real Time Genomics Inc.: Recent Developments, 2016
Table 106 : Smartgene Services SARL: Product Portfolio
Table 107 : Strand Life Sciences: Product Portfolio
Table 108 : Strand Life Sciences: Recent Developments, 2017 and 2018
Table 109 : Syngene International: Product Portfolio
Table 110 : Syngene International: Recent Developments, 2016-2019

List Of Figures


Summary Figure : Overall Global Bioinformatics Market, by Region, 2017-2023
Figure 1 : PDB Data Distribution, by Experimental Method and Molecular Type, 2017
Figure 2 : RefSeq Accession Growth, 2016 and 2018
Figure 3 : Relationship of Bioinformatics with Omic Technologies
Figure 4 : Schematic Representation of Biology Systems and Translational Bioinformatics
Figure 5 : Principles of Precision Medicine
Figure 6 : Applications of Bioinformatics in Drug Development
Figure 7 : Collaboration within the Bioinformatics Arena, by Country, Since 2016
Figure 8 : Number of Drug Approvals, by FDAs CDER, 2008-2018*
Figure 9 : Number of CDERs Annual Novel Drug Approvals, 2009-2018
Figure 10 : The Four Dimensions of Big Data
Figure 11 : Software Scalability of Big Data Bioinformatics
Figure 12 : Software Validation of Big Data Bioinformatics
Figure 13 : Percentage Distribution of Breast Cancer Diagnosis Among the U.S. Women, by Age Group, 2017
Figure 14 : Top-Down Proteomic Approach
Figure 15 : European Bioinformatics Institute Software Solutions
Figure 16 : Evolution of Information Technology Infrastructure
Figure 17 : Schematic Representation of Cloud Computing Services
Figure 18 : Global Bioinformatics Market Share, by Sequencing Services and Platforms, 2017 and 2023
Figure 19 : Global Bioinformatics Market, by Sequencing Services, 2017-2023
Figure 20 : Global Bioinformatics Market, by Sequencing Platform, 2017-2023
Figure 21 : Clinical Bioinformatics for Patients for Precision Health
Figure 22 : Number of Therapeutic Drugs Developed Globally, by Disease Category, 2017
Figure 23 : Classical and Digital Forensics with Respect to Bioinformatics
Figure 24 : Drug Development Process
Figure 25 : Phases in the Drug Discovery and Development Process
Figure 26 : Phase Transition Success Rates and Likelihood of Approvals for All Modalities and Medicines, 2017
Figure 27 : Steps in Drug Discovery
Figure 28 : Information Systems within the Laboratory Architecture
Figure 29 : Application of Bioinformatics in Clinical Trials
Figure 30 : Key Areas of Research Utilizing Bioinformatics

Bioinformatics: Technologies and Global Markets

Report Scope:The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines

USD 5500 View Report

Thermal Ceramics: Technologies and Global Markets

Report Scope:The scope of the study includes discussion of current and upcoming trends of thermal ceramics. In addition, raw material analysis, product life cycle analysis and competitive landscape will also

USD 5500 View Report

2020 Global Salmonella Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

The report presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Salmonella definition,

USD 3850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available